Development Level

Tbio 22 | 11,445
Tchem 11 | 1,598
Tdark 6 | 6,588
Tclin 4 | 613

Collection

Kinase: IDG Consortium (Target... 1 | 125

IMPC Phenotype

abnormal bone mineralization 1 | 38
abnormal cornea morphology 1 | 31
abnormal digit morphology 1 | 10
abnormal skin condition 1 | 6
abnormal testis morphology 1 | 43
decreased IgG3 level 1 | 1
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased circulating alkaline... 1 | 46
decreased circulating amylase ... 1 | 28
decreased circulating choleste... 1 | 93
decreased circulating free fat... 1 | 31
decreased circulating sodium l... 1 | 22
decreased circulating triglyce... 1 | 79
decreased erythrocyte cell num... 1 | 62
decreased hematocrit 1 | 46
decreased hemoglobin content 1 | 68
decreased mature B cell number 1 | 7
decreased mean corpuscular hem... 1 | 31
decreased thermal nociceptive ... 1 | 2
decreased vertical activity 1 | 208
increased IgG1 level 1 | 1
increased IgM level 1 | 1
increased T cell number 1 | 6
increased circulating alkaline... 1 | 122
increased circulating free fat... 1 | 20
increased erythrocyte cell num... 1 | 39
increased lean body mass 1 | 172
increased leukocyte cell numbe... 1 | 47
increased thermal nociceptive ... 1 | 9
increased total body fat amoun... 1 | 134
male infertility 1 | 123
preweaning lethality, complete... 1 | 979
small testis 1 | 58

Disease

Rheumatoid arthritis 18 | 1,191
lung carcinoma 16 | 2,843
lung cancer 15 | 4,740
diabetes mellitus 13 | 1,728
interstitial cystitis 13 | 2,312
osteosarcoma 13 | 7,950
Narcolepsy 12 | 72
cutaneous lupus erythematosus 12 | 1,057
psoriasis 12 | 6,694
sarcoidosis 12 | 370
Berylliosis 11 | 28
Carcinoma 11 | 11,493
ovarian cancer 11 | 8,520
Cancer 10 | 2,499
Multiple Sclerosis, Susceptibility to 10 | 15
Narcolepsy-cataplexy 10 | 21
Systemic lupus erythematosus 10 | 194
invasive ductal carcinoma 10 | 2,951
Diffuse cutaneous systemic sclerosis 9 | 17
Rheumatoid Arthritis, Systemic Juvenile 9 | 16
Sarcoidosis 1 9 | 14
follicular lymphoma 9 | 20
glioblastoma 9 | 5,792
limited scleroderma 9 | 19
primary Sjogren syndrome 9 | 735
Immunologic Deficiency Syndromes 8 | 113
Autosomal recessive predisposition 7 | 1,442
Hypersensitivity reaction type II disease 7 | 253
Juvenile rheumatoid arthritis 7 | 111
Multiple Sclerosis 7 | 540
Schizophrenia 7 | 1,160
adult high grade glioma 7 | 3,801
breast carcinoma 7 | 1,638
subependymal giant cell astrocytoma 7 | 2,287
Type 1 diabetes mellitus 6 | 109
ulcerative colitis 6 | 1,819
Arthritis, Rheumatoid 5 | 174
Autoimmune Diseases 5 | 67
Celiac disease 5 | 116
Infantile onset 5 | 238
Kidney cancer 5 | 2,613
Recurrent respiratory infections 5 | 141
Waldenstrons macroglobulinemia 5 | 765
medulloblastoma, large-cell 5 | 6,241
non-small cell lung cancer 5 | 2,890
tuberculosis 5 | 2,010
Arthralgia 4 | 90
Asthma 4 | 385
Astrocytoma, Pilocytic 4 | 3,081
Diabetes Mellitus, Insulin-Dependent 4 | 48
Diabetes Mellitus, Type 1 4 | 43
Duchenne muscular dystrophy 4 | 601
Eczema 4 | 45
Failure to gain weight 4 | 365
Hepatitis B 4 | 108
Hypersensitivity 4 | 63
Liver diseases 4 | 87
Lymphopenia 4 | 67
Multiple myeloma 4 | 1,332
Pediatric failure to thrive 4 | 365
Recurrent infections 4 | 48
Severe combined immunodeficiency 4 | 51
Urticaria 4 | 67
active Crohn's disease 4 | 922
active ulcerative colitis 4 | 764
astrocytoma 4 | 1,146
ependymoma 4 | 4,679
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
juvenile dermatomyositis 4 | 1,187
Angioedema 3 | 38
Autoimmune thyroiditis 3 | 27
Bipolar Disorder 3 | 666
Brain Ischemia 3 | 110
Cell Transformation, Neoplastic 3 | 97
Chronic Lymphocytic Leukemia 3 | 262
Collagen disease 3 | 27
Crohn's disease 3 | 321
Diarrhea 3 | 253
ESR raised 3 | 20
Erythema 3 | 58
Flushing 3 | 60
Graves' disease 3 | 24
Highly variable severity 3 | 157
Liver Cirrhosis, Experimental 3 | 769
Lymphadenopathy 3 | 62
Lymphoma 3 | 81
Melanoma 3 | 711
Neoplastic Cell Transformation 3 | 89
Pre B-cell acute lymphoblastic leukemia 3 | 5
Proteinuria 3 | 144
Systemic scleroderma 3 | 60
Variable expressivity 3 | 157
Vasculitis 3 | 80
Weight decreased 3 | 103
colon cancer 3 | 1,478
cystic fibrosis 3 | 1,696
ductal carcinoma in situ 3 | 1,745
esophageal adenocarcinoma 3 | 737
pancreatic cancer 3 | 2,398

Tissue

Blood and immune system 25 | 16,909
Liver and Pancreas 25 | 16,750
Respiratory system 25 | 16,393
Skin and soft tissues 25 | 17,230
Digestive Tract 24 | 17,369
Endocrine System 24 | 18,159
Female tissues 24 | 17,400
Male tissues 24 | 17,142
Urinary Tract 24 | 16,678
Cardiovascular System 23 | 15,192
Nervous System 23 | 16,725

Target Family

Non-IDG 33 | 12,091
Enzyme 5 | 4,145
Kinase 3 | 634
Transcription Factor 2 | 1,400

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..